Suchen
MapLight Therapeutics Inc
MPLTZur Watchlist hinzufügen
10.760USD
-0.010-0.09%
Handelsschluss 09-24 16:00（ET）
487.97MMarktkapitalisierung
VerlustKGV TTM
Über Unternehmen
MapLight Therapeutics Inc Profil
Börsenkürzel- -
Name des Unternehmens- -
IPO-datum- -
CEO- -
Anzahl der mitarbeiter- -
Wertpapierart- -
Geschäftsjahresende- -
Addresse- -
Stadt- -
Börse- -
Land- -
Postleitzahl- -
Telefon- -
Website- -
Börsenkürzel- -
IPO-datum- -
CEO- -
Führungskräfte von MapLight Therapeutics Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
180.93K
+3.33%
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
180.93K
+3.33%
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
180.93K
+3.33%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
152.36K
+5.41%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
152.36K
+5.41%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
152.36K
+5.41%
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
10.16K
-538.62%
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
10.16K
-538.62%
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
10.16K
-538.62%
Mr. Martin Babler
Mr. Martin Babler
Independent Director
Independent Director
7.86K
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
180.93K
+3.33%
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
180.93K
+3.33%
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
180.93K
+3.33%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
152.36K
+5.41%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
152.36K
+5.41%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
Interim Chief Financial Officer, Chief Administrative and Chief Accounting Officer
152.36K
+5.41%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von MapLight Therapeutics Inc?
Die fünf größten Anteilseigner von MapLight Therapeutics Inc sind: Dr. Anatol Kreitzer, Ph.D.